2018 annual financial data
REGENXBIO 2018 Net margin
REGENXBIO 2018 net margin with verified reported values.
Direct answer
Net margin was 45.74%.
Operating income was 88,100,000 USD and net income was 99,937,000 USD.
Operating cash flow was 104,648,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 218,505,000 USD
- Operating income
- 88,100,000 USD
- Net income
- 99,937,000 USD
- Operating cash flow
- 104,648,000 USD